Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) major shareholder Marlio Charles Mosseri acquired 1,176 shares of the business’s stock in a transaction dated Wednesday, July 5th. The stock was bought at an average cost of $15.52 per share, with a total value of $18,251.52. Following the acquisition, the insider now owns 2,529,201 shares in the […]